These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26503077)

  • 1. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB; Sanchez JE; Lau SK; Greenberg SM; Raval NY; Worley S; Kalman J; Merliss AD; Krueger S; Wood M; Wish M; Burkhoff D; Nademanee K
    Heart Rhythm; 2006 Oct; 3(10):1140-7. PubMed ID: 17018340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
    Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Giallauria F; Vigorito C; Piepoli MF; Stewart Coats AJ
    Int J Cardiol; 2014 Aug; 175(2):352-7. PubMed ID: 24975782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure.
    Schau T; Seifert M; Meyhöfer J; Neuss M; Butter C
    Europace; 2011 Oct; 13(10):1436-44. PubMed ID: 21712286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
    Abraham WT; Kuck KH; Goldsmith RL; Lindenfeld J; Reddy VY; Carson PE; Mann DL; Saville B; Parise H; Chan R; Wiegn P; Hastings JL; Kaplan AJ; Edelmann F; Luthje L; Kahwash R; Tomassoni GF; Gutterman DD; Stagg A; Burkhoff D; Hasenfuß G
    JACC Heart Fail; 2018 Oct; 6(10):874-883. PubMed ID: 29754812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Abraham WT; Nademanee K; Volosin K; Krueger S; Neelagaru S; Raval N; Obel O; Weiner S; Wish M; Carson P; Ellenbogen K; Bourge R; Parides M; Chiacchierini RP; Goldsmith R; Goldstein S; Mika Y; Burkhoff D; Kadish A;
    J Card Fail; 2011 Sep; 17(9):710-7. PubMed ID: 21872139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
    Stix G; Borggrefe M; Wolpert C; Hindricks G; Kottkamp H; Böcker D; Wichter T; Mika Y; Ben-Haim S; Burkhoff D; Wolzt M; Schmidinger H
    Eur Heart J; 2004 Apr; 25(8):650-5. PubMed ID: 15084369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Mando R; Goel A; Habash F; Saad M; Ayoub K; Vallurupalli S; Maskoun W
    Cardiovasc Ther; 2019; 2019():9769724. PubMed ID: 31772622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
    Wiegn P; Chan R; Jost C; Saville BR; Parise H; Prutchi D; Carson PE; Stagg A; Goldsmith RL; Burkhoff D
    Circ Heart Fail; 2020 Apr; 13(4):e006512. PubMed ID: 32264716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac contractility modulation: a novel approach for the treatment of heart failure.
    Abi-Samra F; Gutterman D
    Heart Fail Rev; 2016 Nov; 21(6):645-660. PubMed ID: 27394714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure.
    Borggrefe M; Burkhoff D
    Eur J Heart Fail; 2012 Jul; 14(7):703-12. PubMed ID: 22696514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Liu M; Fang F; Luo XX; Shlomo BH; Burkhoff D; Chan JY; Chan CP; Cheung L; Rousso B; Gutterman D; Yu CM
    Int J Cardiol; 2016 Mar; 206():122-6. PubMed ID: 26788686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.